MIT finds genetic clue to bone and fat production

MIT researchers have identified a gene that helps control the balance between bone and fat in the human body, a discovery that could pave the way for the prevention of childhood obesity and the treatment of osteoporosis.

The findings will be published in the Aug. 12 issue of Science.

Researchers at MIT's Center for Cancer Research found that a gene called TAZ works to control the destiny of adult bone marrow stem cells, also known as mesenchymal stem cells (MSCs). MSCs have the potential to form a number of different cell types, including bone, fat and muscle.

"We show that a single molecule helps turn one set of genes on to form bone and another set of genes off to inhibit fat formation in MSCs," said Michael Yaffe, the Howard and Linda Stern Professor of Biology and senior author of the paper. "This result suggests a potential new approach to combating various human diseases that result from a disruption in the balance between bone and fat."

The research presents several therapeutic opportunities, including the possibility that once isolated from the bone marrow, MSCs could be useful for healing bone fractures.

"One could also imagine developing a drug to stimulate TAZ activity, which may promote bone growth in elderly patients with osteoporosis," Yaffe said. "And because of the simultaneous inhibitory effect of TAZ on fat cell development, the same drug might also be used to prevent childhood obesity."

It would also be interesting to investigate whether TAZ activity is defective in bone tumors, and in bone-like tumors that form from fat cells, the researchers said. Modulating TAZ activity could be an effective approach to treating these tumors.

The researchers studied the function of TAZ in cultured MSCs and in animals. MSCs comprise a small percentage of bone marrow cells, about 0.01 percent.

The researchers' most stunning result came when they injected one- to two-cell zebrafish embryos with short strands of RNA that blocked expression of the TAZ gene.

"When we knocked out TAZ in zebrafish, the embryos died when they were just 8 days old, and they had failed to form any bones at all," said postdoctoral fellow Jeong-Ho Hong, the lead author on the paper. Therefore, depletion of TAZ within the body completely impaired bone development. When TAZ was depleted in MSCs grown outside the body in culture, those cells readily turned into fat.

The research was borne out of a collaboration between Yaffe, who also holds appointments in the Broad Institute and in the Department of Surgery at Beth Israel Deaconess Medical Center; Harvard Medical School; the CCR labs of Nancy Hopkins, Amgen Professor of Biology, and Phillip Sharp, Institute Professor of biology; and the lab of Bruce Spiegelman at the Dana-Farber Cancer Institute and Harvard Medical School.

MIT CCR researchers Michael T. McManus, Adam Amsterdam and Ralitsa Kalmukova, Harvard Medical School researchers Eun Sook Hwang of the Harvard School of Public Health, Yu Tian and Thomas Benjamin of the Department of Pathology, and Elisabetta Mueller and Bruce M. Spiegelman of the Dana-Farber Cancer Institute and the Department of Cell Biology also contributed to this work.

Source: MIT

Related stories:

Bone marrow stem cells may help control inflammatory bowel disease
Massachusetts General Hospital (MGH) investigators have found that infusions of a particular bone marrow stem cell appeared to protect gastrointestinal tissue from autoimmune attack in a mouse model. In their report published in the journal Stem Cells, the team from the MGH Center for Engineering in Medicine report that mesenchymal stem cells (MSCs), known to control several immune system activities, allowed the regeneration of the gastrointestinal lining in mice with a genetic mutation leading to multiorgan autoimmune disease.
Scientists uncover the potential to control adult stem cells
Research being presented today at the UK National Stem Cell Network Annual Science Meeting in Edinburgh represents a step towards the use of Adult Stem Cells (ASCs) to repair damaged tissue. Speaking at the conference in Edinburgh, Professor Cay Kielty of the University of Manchester describes how she and her team have uncovered a messaging system that instructs ASCs to contribute to tissue repair in response to chemical signals in the body.
Cancer drug activates adult stem cells
The use of a drug used in cancer treatment activates stem cells that differentiate into bone appears to cause regeneration of bone tissue and be may be a potential treatment strategy for osteoporosis, according to a report in the February 2008 Journal of Clinical Investigation.
Turning on adult stem cells may help repair bone
The use of a drug to activate stem cells that differentiate into bone appears to cause regeneration of bone tissue and be may be a potential treatment strategy for osteoporosis, according to a report in the February 2008 Journal of Clinical Investigation.
Cancer cells enlist adult stem cells to promote metastasis
Everyone knows that tumors are packed with cancer cells, but many normal cells live among these deviants. The normal cells form a structural framework called the stroma, which was once thought to resemble passive scaffolding. But a growing body of research suggests that cancer cells actively recruit normal cells from local and distant sites to the scaffolding, where they release signals that help the tumor thrive.
Type of stem cell found to reside in transplanted lungs
A new study involving a type of stem cells from the lungs of transplant patients demonstrates for the first time that these progenitor cells reside in adult organs and are not derived from bone marrow, which leads to the possibility that the cells may be able to help with the rejection of donated organs and with various kinds of lung disease.
Molecular 'marker' on stem cells aids research, perhaps therapies
A sugar molecule present on embryonic stem cells also has been found on the surface of a type of adult stem cell, a discovery that may help researchers isolate and purify adult stem cells for use in therapies aimed at bone healing, tendon repair and cartilage regeneration, researchers at UT Southwestern Medical Center report.
One-off treatment to stop back pain -- Using patients' own stem cells
A University of Manchester researcher has developed a treatment for lower back pain using the patient’s own stem cells, which could replace the use of strong painkillers or surgery that can cause debilitation, neither of which addresses the underlying cause.

News discussion:

General Science news